Home | Structured Search | Drug Resource
Find: within
Posttraumatic Stress Disorder > Diagnosis Author: Jeffrey P. Staab, MD, MS
Editorial changes - 2010-01-20
Author information and module status
Prevention
Screening
Diagnosis
Consultation for Diagnosis
Hospitalization
Non-drug Therapy
Drug Therapy
Patient Education
Consultation for Management
Follow-up
Tables
References
Glossary
What's New
Patient Information
Additional Resources
Tools

Rationale:

  • PTSD is not the only adverse psychological outcome of traumatic events.

Evidence:

  • The comorbidity of PTSD with mood, anxiety, and substance-related disorders is 30% or more. Rates of interpersonal violence also are higher among individuals exposed to traumatic stressors (2; 7; 8; 9).

Comments:

  • A systematic approach is needed to assess the full range of psychiatric symptoms that may follow a traumatic stressor. Assessment can be done efficiently and will ensure that effective treatment is rendered.

FAQs
Jeffrey P. Staab, MD, MS, is a consultant for Eli Lilly, Forest Laboratories, received honorarium from Abbott Laboratories, received grants from GlaxoSmithKline, Pfizer. Michael Roy, MD, editorial consultant, received honorarium from PFizer.
Darren B. Taichman, MD, PhD, Editor, PIER, has received grant support from Actelion Pharmaceuticals Ltd , and honoraria for continuing medical education grand rounds and lectures given.

The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted (c) 2010 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.